Columbia

The test is designed to detect the SARS-CoV-2 nucleocapsid gene in nasopharyngeal, oropharyngeal, nasal, and midturbinate nasal swab samples.

Research institutions in the US and Europe will lead the studies, which will explore different aspects of COVID-19 such as host immune response.

Investigators worldwide are sharing data to search for features in the human genome that might contribute to COVID-19 susceptibility or progression.

An analysis of cases and controls from South Africa's Xhosa population pointed to private, damaging mutations in genes expressed in the brain.

The partners are studying wild-type cardiac amyloidosis, a rare condition characterized by the accumulation of abnormal proteins in the heart.

The project is part of the Human Cell Atlas, an international effort to build reference maps of all human cell types using single-cell analysis.